Pulmonary sarcoidosis in a preschool patient

Shivanthan Shanthikumar1, Jo Harrison1

  • 1Respiratory Department, Royal Children's Hospital, Melbourne, Australia.

Pediatric Pulmonology
|June 30, 2015
PubMed

Insights

Pediatric pulmonary sarcoidosis is rare in preschoolers, typically affecting eyes, joints, and skin. This case highlights successful treatment of lung-only sarcoidosis in a 4-year-old using intravenous pulse methylprednisolone.

Area of Science:

  • Pediatric Pulmonology
  • Rheumatology
  • Immunology

Background:

  • Sarcoidosis is a rare multisystem granulomatous disease.
  • Preschool sarcoidosis commonly involves eyes, joints, and skin, sparing the lungs.
  • Oral prednisolone is the standard first-line treatment for pediatric sarcoidosis.

Observation:

  • A 4-year-old boy presented with isolated pulmonary sarcoidosis, a rare presentation for this age group.
  • The patient exhibited no involvement of other organs, such as eyes, joints, or skin.
  • Standard treatment protocols for pediatric sarcoidosis were considered.

Findings:

  • The child was successfully treated with intravenous pulse methylprednisolone followed by oral prednisolone.
  • This treatment regimen resulted in a positive clinical outcome.
  • The case demonstrates a novel and effective approach to managing pediatric pulmonary sarcoidosis.

Implications:

  • This case expands the understanding of rare preschool sarcoidosis presentations.
  • Intravenous pulse methylprednisolone offers a potentially effective treatment for pediatric pulmonary sarcoidosis.
  • Further research into novel treatment strategies for early-onset sarcoidosis is warranted.

Related Concept Videos

Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
2.0K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.2K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.5K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
5.0K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.5K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
897